Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Clement

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|March 1, 1991
Synthesis and antitumor activity of structural analogues of the epipodophyllotoxinsL L Klein, C M Yeung, D T Chu, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1991
In vitro activity and in vivo efficacy of a new series of 9-deoxo-12-deoxy-9,12-epoxyerythromycin A derivativesD J Hardy, R N Swanson, N L Shipkowitz, et al.
Biochemistry|September 20, 1994
Quinobenoxazines: a class of novel antitumor quinolones and potent mammalian DNA topoisomerase II catalytic inhibitorsP A Permana, R M Snapka, L L Shen, et al.
The Journal of Antibiotics|March 1, 1997
Production of brominated tiacumicin derivativesJ E Hochlowski, M Jackson, R R Rasmussen, et al.
Journal of Medicinal Chemistry|December 1, 1991
Synthesis and antibacterial activities of C-21 functionalized derivatives of (9R)-9-amino-9-deoxoerythromycins A and BP A Lartey, S L DeNinno, R Faghih, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1994
In vitro and in vivo evaluations of A-80556, a new fluoroquinoloneJ J Clement, S K Tanaka, J Alder, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1991
In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficileR N Swanson, D J Hardy, N L Shipkowitz, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1995
In vitro evaluation of ABT-719, a novel DNA gyrase inhibitorR K Flamm, C Vojtko, D T Chu, et al.
Chemico-Biological Interactions|February 1, 1986
Potential antiradiation drugs containing no nitrogen, and related compoundsG T Bowman, J J Clement, D E Davidson, et al.
The Journal of Antibiotics|June 1, 1996
Novel triterpene sulfates from Fusarium compactum using a rhinovirus 3C protease inhibitor screenG M Brill, W M Kati, D Montgomery, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|March 1, 1991
Synthesis and antitumor activity of structural analogues of the epipodophyllotoxinsL L Klein, C M Yeung, D T Chu, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1991
In vitro activity and in vivo efficacy of a new series of 9-deoxo-12-deoxy-9,12-epoxyerythromycin A derivativesD J Hardy, R N Swanson, N L Shipkowitz, et al.
Biochemistry|September 20, 1994
Quinobenoxazines: a class of novel antitumor quinolones and potent mammalian DNA topoisomerase II catalytic inhibitorsP A Permana, R M Snapka, L L Shen, et al.
The Journal of Antibiotics|March 1, 1997
Production of brominated tiacumicin derivativesJ E Hochlowski, M Jackson, R R Rasmussen, et al.
Journal of Medicinal Chemistry|December 1, 1991
Synthesis and antibacterial activities of C-21 functionalized derivatives of (9R)-9-amino-9-deoxoerythromycins A and BP A Lartey, S L DeNinno, R Faghih, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1994
In vitro and in vivo evaluations of A-80556, a new fluoroquinoloneJ J Clement, S K Tanaka, J Alder, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1991
In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficileR N Swanson, D J Hardy, N L Shipkowitz, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1995
In vitro evaluation of ABT-719, a novel DNA gyrase inhibitorR K Flamm, C Vojtko, D T Chu, et al.
Chemico-Biological Interactions|February 1, 1986
Potential antiradiation drugs containing no nitrogen, and related compoundsG T Bowman, J J Clement, D E Davidson, et al.
The Journal of Antibiotics|June 1, 1996
Novel triterpene sulfates from Fusarium compactum using a rhinovirus 3C protease inhibitor screenG M Brill, W M Kati, D Montgomery, et al.
Pageof 5